Previous 10 | Next 10 |
Pixabay Data is the foundation of investing. Most investment focuses on data in the form of earnings per share, PE multiple, revenue growth, PEG ratio, etc. Biotech clinical results are based upon data. This article is a vehicle to present alternative data used to help understand clinical ...
This article explains the reasons behind the movement in a selection of the largest U.S. cash merger arbitrage spreads from the past week as calculated by Merger Arbitrage Limited. We analyze the attractiveness and profitability of each spread going forward and indicate the trading position ...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify (click the highlighted links). Sterling fell below $1.20 overnight , hitting its lowest level since the October 2016 flash crash, ...
This article is part of a series that provides an ongoing analysis of the changes made to John Paulson's 13F stock portfolio on a quarterly basis. It is based on Paulson's regulatory 13F Form filed on 08/14/2019. Please visit our Tracking John Paulson's Paulson & Company Portfolio serie...
PHILADELPHIA, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE), a fully-integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, announced today the location of its 2019 Annual Meeting of Stockholders, to be held on Sept. 5...
This article is part of a series that provides an ongoing analysis of the changes made to Prem Watsa’s 13F portfolio on a quarterly basis. It is based on Watsa’s regulatory 13F Form filed on 08/14/2019. Please visit our Tracking Prem Watsa’s Fairfax Financial Holdings P...
Four of my favorite times of the trading year are the days that Form 13F filings are released. Those filings give all investors and traders a chance to see what the big money is buying, selling or holding. In particular I am interested in the funds that invest largely in M&A stocks. I tr...
Merger activity increased last week with seven new deals announced and four pending deals closing. In the context of the merger of Sprint (S) with T-Mobile (TMUS), it was interesting to see a large insider purchase by the Chairman of DISH Network (DISH). Deal Statistics: New Deals: ...
Five short months ago, Sangamo ( SGMO ) released their 2018 results , providing a program review which refocused development priorities. Gene editing trials for hemophilia B, MPS I and MPS II were put on hold. Gene and cell therapies became the more immediate opportunities. Hemophilia A becam...
We already know that this is a crazy financial world we live in: Global Manufacturing is Crashing Investors Run to Safety Monetary Policy Made a Sharp U-Turn Bonds Have Gone Mad Recession Seems More and More Likely In such a world, it's no wonder t...
News, Short Squeeze, Breakout and More Instantly...
Spark Therapeutics Inc. Company Name:
ONCE Stock Symbol:
NASDAQ Market:
Spark Therapeutics Inc. Website:
Genetics is the study of genes, their variations and hereditary characteristics. As Live Science describes it , genetics involves looking at how traits are passed on through generations. So, what is genetics investing? When it comes to genetics investing, companies in this niche...
After big biopharma Astellas (OTC: ALPMY) (OTC: ALPMF) agreed to acquire clinical-stage gene therapy company Audentes Therapeutics (NASDAQ: BOLD) for $3 billion in cash, uniQure 's (NASDAQ: QURE) shares have jumped 13% at 12:15 pm EDT on Tuesday. Although Audentes and uni...
PHILADELPHIA, Oct. 25, 2019 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that the Galien Foundation has awarded the prestigious 2019 Prix Galien USA Aw...